Glenmark Pharma Gains Fda Approval for Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution.

Glenmark Pharma Gains Fda Approval for Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution.

By, Admin 20 May 2024

Glenmark Pharma receives US FDA approval for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%

Overview

Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%. Glenmark’s brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5% has been determined by the FDA to be bioequivalent and therapeutically equivalent to Combigan ophthalmic solution, 0.2%|0.5%, of AbbVie, Inc., and will be distributed in the US by Glenmark Pharmaceuticals Inc., USA. 

Approximate Annual Sales

According to IQVIA sales data for the 12-month period ending March 2024, the Combigan ophthalmic solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million.

Glenmark’s Portfolio

  • Glenmark’s current portfolio consists of 196 products authorized for distribution in the US marketplace and 51 ANDA’s pending approval with the US FDA. 
  • In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio. 

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. is a research-led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!